Korean Circ J.  2018 Nov;48(11):1028-1029. 10.4070/kcj.2018.0179.

Defining Coronary Artery Perforation with Ultrasound Contrast Agent

Affiliations
  • 1Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University, Wonju, Korea.
  • 2Division of Cardiovascular Medicine, Calhoun Cardiovascular Center, University of Connecticut School of Medicine, Farmington, CT, USA. azrin@uchc.edu

Abstract

No abstract available.


MeSH Terms

Coronary Vessels*
Ultrasonography*

Figure

  • Figure 1 Coronary angiography and contrast echocardiography. (A) Post-stenting angiography shows CAP in the LAD (white arrowheads), but it is not definitive whether this perforation emptied into the pericardium (Ellis classification III) or into the RV (Ellis classification III cavity spilling). (B) After injection of UCA into the LAD, the rapid and dense appearance of UCA in the RV on echocardiography confirms the CAP of Ellis classification III cavity spilling. CAP = coronary artery perforation; LAD = left anterior descending coronary artery; LV = left ventricle; RV = right ventricle; UCA = ultrasound contrast agent.


Reference

1. Ellis SG, Ajluni S, Arnold AZ, et al. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation. 1994; 90:2725–2730.
Article
2. Oreglia JA, Bruschi G, Klugmann S. Percutaneous treatment of iatrogenic left-anterior descending artery to right ventricle fistula. Catheter Cardiovasc Interv. 2010; 76:975–977.
Article
3. Main ML, Hibberd MG, Ryan A, Lowe TJ, Miller P, Bhat G. Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent. JACC Cardiovasc Imaging. 2014; 7:40–48.
Article
4. Muskula PR, Main ML. Safety with echocardiographic contrast agents. Circ Cardiovasc Imaging. 2017; 10:e005459.
Article
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr